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Abstract
Antibiotic resistance is a global challenge that impacts all pharmaceutically used antibiotics. The origin of the genes
associated with this resistance is of significant importance to our understanding of the evolution and dissemination of
antibiotic resistance in pathogens. A growing body of evidence implicates environmental organisms as reservoirs of these
resistance genes; however, the role of anthropogenic use of antibiotics in the emergence of these genes is controversial. We
report a screen of a sample of the culturable microbiome of Lechuguilla Cave, New Mexico, in a region of the cave that has
been isolated for over 4 million years. We report that, like surface microbes, these bacteria were highly resistant to
antibiotics; some strains were resistant to 14 different commercially available antibiotics. Resistance was detected to a wide
range of structurally different antibiotics including daptomycin, an antibiotic of last resort in the treatment of drug resistant
Gram-positive pathogens. Enzyme-mediated mechanisms of resistance were also discovered for natural and semi-synthetic
macrolide antibiotics via glycosylation and through a kinase-mediated phosphorylation mechanism. Sequencing of the
genome of one of the resistant bacteria identified a macrolide kinase encoding gene and characterization of its product
revealed it to be related to a known family of kinases circulating in modern drug resistant pathogens. The implications of
this study are significant to our understanding of the prevalence of resistance, even in microbiomes isolated from human
use of antibiotics. This supports a growing understanding that antibiotic resistance is natural, ancient, and hard wired in the
microbial pangenome.
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Introduction
The question of whether the extensive presence of resistance
elements in microbes is primarily the result of human activity is
controversial. Investigation of antibiotic resistance in bacteria from
the Galapagos, a remote environment with limited human
occupation and presumably low anthropogenic antibiotic expo-
sure, revealed that acquired antibiotic resistance genes were absent
in bacteria isolated from terrestrial animals [1]. Similarly, plasmids
from bacterial collections that predate the antibiotic era are largely
devoid of resistance elements [2,3]. This suggests that the presence
of antibiotics is an important selective force in evolution and
spread of antibiotic resistance genes and can contribute signifi-
cantly in altering the natural microbiota. In a survey of soil
samples from the Netherlands spanning the pre-and post-antibiotic
eras (1940–2008), an increase in the relative abundance of
antibiotic resistance genes for major antibiotic families (ß-lactams,
tetracyclines and macrolides) was observed in contemporary soil
samples in comparison to pre-antibiotic era samples [4]. This body
of evidence is consistent with the hypothesis that widespread
resistance is a modern phenomenon linked to human use of
antibiotics.
On the other hand, antibiotics and antibiotic biosynthetic
pathways are believed to have evolved over millions of years
suggesting that antibiotic resistance is an equally ancient
phenomenon [5,6,7]. Indeed, we have recently shown that
antibiotic resistance elements were abundant and diverse in
ancient DNA dating from the Pleistocene (30,000 years ago) [8].
The concept of the antibiotic resistome predicts that resistance is
the result of dynamic and competitive microbial interactions that
pre-date human use of antibiotics [9,10]. Consistent with this
notion is our survey of contemporary soil actinomycetes that
reported widespread multidrug resistance even in the absence of
obvious human sources of antibiotics [11]. There have also been
reports of antibiotic resistance in microorganisms isolated from
extreme natural habitats including the deep terrestrial subsurface
[12] and the deep ocean [13]; environments presumably largely
absent of human influence. These studies support a hypothesis that
resistance is an ancient and genetically rich natural phenomenon,
deeply embedded in the microbial pangenome.
One of the challenges in measuring contemporary environ-
mental resistance is rigorously ensuring the absence of anthropo-
genic sources of antibiotics as a selective pressure for the
acquisition of ‘modern’ resistance genes. A survey of a diverse
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modern antibiotics and resistance genes would unequivocally
establish the depth of the contemporary environmental resistome:
Lechuguilla Cave offers a unique environment for such a study.
Lechuguilla Cave, located within Carlsbad Caverns National
Park (USA), was formed in the Capitan Formation of the
Delaware Basin by hypogenic (ascending water) sulfuric acid
speleogenesis in the last 7 million years [14,15,16], resulting in the
formation of a very large (.200 km) and deep (.500 m), maze-
like cave system [17]. While the cave is still connected to the
artesian aquifer that formed it (Figure 1), the majority of the cave
became isolated as the aquifer dropped [18]. Due to its isolated
hypogene nature, extensive cave development occurred primarily
at 2300 to 2400 m, while the impermeable Yates Formation that
overlies the cave limits vadose water from entering the system
[14,17,19]. The deep recesses of Lechuguilla Cave, isolated from
surface input for the past 4–7 million years, therefore provide a
unique environment to study the presence and prevalence of
antibiotic resistance elements.
We report here a sampling of the culturable Lechuguilla Cave
resistome – the antibiotic resistance genes found in a culture
collection of isolates from this cave environment. In addition to
finding a wide array of resistance in this culture collection, we also
describe a novel macrolide kinase variant and an inducible
daptomycin hydrolase, demonstrating not only that resistance is
prevalent in the absence of anthropogenic antibiotics, but hitherto
undiscovered mechanisms of resistance that have potentially
important clinical implications are prevalent in the environment.
Figure 1. Plan and profile maps of Lechuguilla Cave, Carlsbad Caverns National Park, New Mexico. The sites where microbial strains
were collected (LCECE, LCDS1 and LCEA1) are shown relative to the entrance and depth. tN represents true North on the plan, while the profile has an
exaggerated vertical profile of 1.56.
doi:10.1371/journal.pone.0034953.g001
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Sampling of the Lechuguilla Cave Culturable Microbiome
Since its discovery in 1986, Lechuguilla Cave has been closed to
human access without a permit. The sample areas were chosen off
the designated trail through the cave, in areas that have
experienced very little human impact (National Park records
suggest that a maximum of 4–6 people have been in the vicinity of
each sample site) (Figure 1). Specific sample locations were chosen
due to the unlikelihood that these areas were actually exposed to
human visitation: absence of footprints and scuffmarks that usually
indicate human activity. Three sample sites were chosen, based on
location and geology: LCDS1 and LCEAE (deep and within the
Capitan Formation) and LCEA1 (mid-depth in the Yates
Formation). None of the sites received any direct source of water
with any moisture likely to come via percolation from the surface
or from condensation events within the cave atmosphere. LCDS1
was the deepest sample site (at 2400 m) within a region known as
Deep Secrets and LCEAE was in the proximity of the LCDS1
sample site at the same depth. LCEA1 was chosen as an area that
has been closed to human access for the past 20 years, with the
only human activity in the area being carried out by scientists. The
LCEA1 sample is at the bottom of the Yates Formation, which is
high in iron and manganese and is the rock unit in which much of
the oil and gas is extracted from the Delaware Basin. As a result,
this rock unit is usually associated with organic material from
ancient sediments [14].
A total of 20 different culture media were inoculated at each
sample site, resulting in the isolation of over 500 unique isolates
(Text S1) [20]. Of these, 93 that were able to grow in 50% TSB
were chosen at random to screen for antibiotic resistance in this
fraction of the cave microbiome (Table S1, Figure S1). These
bacteria were phylogenetically classified by sequencing of the 16 S
rRNA gene sequence (Table S2) and spanned several Gram-
positive and Gram-negatives genera known to be associated with
cave environments [21,22,23,24,25,26,27].
Antibiotic Resistance Screen of the Lechuguilla
Microbiome
The Lechuguilla bacterial collection (93 strains, 33% Gram-
positive and 63% Gram-negative) was screened against 26
different antimicrobial agents representing a broad spectrum of
natural products, their semi-synthetic derivatives, and completely
synthetic molecules (Figure 2). In the primary screen, the level of
resistance was assessed by monitoring the growth at 20 mg/ml
drug concentration (a high level of antibiotic to select for robust
resistance) and resistance in the primary screen was defined as
.50% growth in the presence of antibiotic, consistent with other
surveys of resistance [11,28]. Resistant and sensitive strains
obtained from the primary screen were further quantitatively
analyzed by determination of the minimal inhibitory concentra-
tion (MIC) of the antibiotics (Figure 3).
Resistance spanned most of the major drug families in both
Gram-positive and Gram-negative strains. In the collection of 33
Gram-positive strains, on average, 70% of the strains were
resistant to 3–4 different antibiotic classes. Three strains were
resistant to 14 antibiotics, all of which were Streptomyces spp. These
values are consistent with those found in surface Streptomyces [11];
however, unlike surface strains, we saw no Gram-positive
resistance to the synthetic drugs ciprofloxacin and linezolid, the
semi synthetic compounds rifampicin and minocycline, and the
natural product vancomycin (Figures 2–3).
Gram-negative bacteria are intrinsically resistant to many
classes of antibiotics due to the presence of the relatively
impermeant outer membrane along with the presence of chemo-
selective porins and highly efficient small molecule efflux pumps.
Therefore, only antibiotics known to have activity against Gram-
negatives were included in the data analysis. On average,
approximately 65% of the Gram-negative strains showed
resistance to 3–4 antibiotic classes. No tetracycline resistance was
observed, though it is common in surface bacteria [29,30,31]. On
the other hand, resistance to sulfamethoxazole, trimethoprim, and
fosfomycin was common; a feature shared with surface bacteria
(Figures 2–3).
Antibiotic Inactivation by Gram-positive isolates
Enzymes that modify antibiotics are of particular interest as they
most likely evolved in direct response to the emergence of specific
antibiotics to block their activity in contrast to mechanisms such as
efflux that often can target several classes of bioactive compounds
of diverse chemical structure [32]. Within the isolates, we detected
no inactivation of aminoglycosides, the lincosamide clindamycin,
or chloramphenicol; antibiotics where enzymatic inactivation is a
prevalent resistance mechanism in surface bacteria (Table 1) [33].
On the other hand, substantial inactivation (22–62% of strains)
was seen for ß-lactams (the penicillins ampicillin, piperacillin and
the cephalosporin cephalexin), which is primarily caused by the
hydrolysis of ß-lactam ring by ß-lactamases (Table 1) [34].
Enzymatic inactivation was detected for macrolide antibiotics in
four strains: three isolates of Streptomyces spp. and one of
Brachybacterium paraconglomeratum (Table S3). These strains inacti-
vated both the natural product erythromycin and its 3
rd generation
semi-synthetic derivative telithromycin. Inactivation by the
Streptomyces isolates yielded a product with a mass increase of
162, consistent with mono-glycosylation of the antibiotic [11,35].
Inactive macrolide antibiotics from B. paraconglomeratum extracts on
the other hand revealed a mass increase of 80, indicative of
inactivation by phosphorylation (Figure 4) [36].
The lipopeptide daptomycin is the newest class of antibiotic
approved for clinical use. Three Streptomyces strains were found to
be highly resistant to daptomycin (MIC$256 mg/ml) and
inactivated the antibiotic through hydrolysis as assessed by LC/
MS (m/z increase of 18 g/mol). This result is consistent with the
high level of daptomycin inactivation in surface Streptomyces where
this is a constitutively expressed activity [11,37]. Additionally, four
isolates of Paenibacillus lautus completely inactivated daptomycin
when grown at sub-MIC concentration of the antibiotic.
Daptomycin inactivation has not been previously reported in
low G+C bacteria (Firmicutes bacteria). Purification of the inactive
product followed by MS/MS analysis revealed hydrolytic cleavage
of the ester bond between the threonine and kynurenine residues
resulting in ring-opening inactivation (Table S4). The inactivation
of daptomycin was highly sensitive to inhibition by EDTA, but not
significantly by Ser esterase/protease inhibitors (Figure S2),
consistent with the possible involvement of a metallo-esterase.
This contrasts with our recent analysis of Streptomyces daptomycin
esterases, which appear to use canonical Ser catalytic triad
chemistry to inactivate the antibiotic [37]. Furthermore, unlike
inactivation by Streptomyces, which appears to be constitutively
expressed, the production of the inactivating activity in P. lautus
was inducible by exposure to daptomycin (Figure 5). To explore if
this activity was unique to the cave isolate, we obtained a surface
strain of P. lautus (ATCC 43898) and observed similar results in
enzymatic inactivation and antibiotic-associated induction of
activity.
Antibiotic Resistance in Cave Bacteria
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We observed little enzyme-mediated antibiotic inactivation in
Gram-negative isolates (Table 2), suggesting that there are other
molecular mechanisms of resistance at play such as efflux, target
modification, or barriers to entry. Three strains belonging to the
genera Agrobacterium and Ochoromobactrum displayed chloramphen-
icol inactivation, which we determined by LC/MS to be the
modification by acetylation (Table S5); a well-established resis-
tance mechanism both in Gram-positive and Gram-negative
bacteria [33].
Characterization of a B. paraconglomeratum macrolide
kinase
Phosphorylation of macrolides in pathogenic bacteria is a
growing clinical problem [38] catalyzed by a family of macrolide
phosphotransferases (MPHs) [36,39]. In order to probe for the
presence of possible mph genes in macrolide inactivating B.
paraconglomeratum, we prepared a draft genome sequence using
Roche 454 and Illumina platforms. A gene encoding a predicted
macrolide kinase, mphE, was identified (Figure 6). We expressed
the gene product in E. coli, purified the enzyme and determined its
activity and specificity using steady state kinetics (Table 3). The
enzyme efficiently modified 14-, 15-, and 16-membered macrolide
antibiotics aligning this enzyme with known type II MPHs (based
on previous characterization of these enzymes in E. coli isolates)
[40,41]. The regiospecificity of phosphorylation of telithromycin
was determined by multidimensional and multinuclear magnetic
resonance analysis to be at the 29-hydroxyl group of the
desosamine sugar (Figures S3 and S4, Tables S6 and S7).
The genome of another Brachybacterium species has been
reported, Brachybacterium faecium DSM 4810, a terrestrial soil isolate
Figure 2. Resistance levels of Lechuguilla cave bacteria at 20 mg/ml against various antibiotics: (top) Gram-positive strains (bottom)
Gram-negative strains. Antibiotics are grouped according to their mode of action/target, where each color represents a different target.
doi:10.1371/journal.pone.0034953.g002
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aminoglycoside kinase, that is 72% identical at the amino acid
level to the B. paraconglomeratum MPH. Expression, purification and
analysis of the B. faecium enzyme revealed similar antibiotic
substrate profiles and activity as the MPH encoded by the mphE
gene in B. paraconglomeratum, with no aminoglycoside modification
activity (Table 4).
Figure 3. MIC of antibiotics determined in this study. Heat Plot for (A) Gram-positive strains (B) Gram-negative strains against various
antibiotics. Antibiotics are grouped according to their mode of action and the gradient from light blue to dark blue represents the range from lowest
MIC value (0.3 mg/ml) to highest MIC value (256 mg/ml) as shown in the legend. White means no MIC was determined.
doi:10.1371/journal.pone.0034953.g003
Table 1. Summary of Antibiotic Inactivation Studies for Gram-positive Isolates.
Antibiotic Resistant Strains Number of antibiotic Inactivation Strains Mechanism of Inactivation
Apramycin 7 0 -------
Gentamicin 5 0 -------
Neomycin 8 0 -------
Streptomycin 8 0 -------
Tetracycline 4 0 -------
Minocycline 1 0 -------
Clindamycin 6 0 -------
Chloramphenicol 12 0 -------
Synercid 2 0 -------
Erythromycin 7 1 Phosphorylation
Telithromycin 4 4 Phosphorylation Glycosylation
Linezolid 2 0 -------
Novobiocin 5 0 -------
Cephalexin 17 5 Hydrolysis
Ampicillin 8 5 Hydrolysis
Piperacillin 9 2 Hydrolysis
Daptomycin 24 7 Hydrolysis
Strains were grown in 50% TSB for 5 days in presence of 20 mg/ml antibiotic. Conditional media was used for setting up disk diffusion assays and LC-MS analyses.
Inactivation was defined as the absence of a zone of clearance around the disk. Hydrolytic mechanism of ß-lactam resistance is inferred.
doi:10.1371/journal.pone.0034953.t001
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comparable regions of the chromosome and flanked by similar
genes and synteny (Figure 6); a survey 10 kb upstream and
downstream of mph revealed eleven common and five different
genes (Figure 6) and the gene products were 75–80% similar.
Phylogenetic analysis shows that MPHs from Brachybacterium strains
cluster together as a separate group among the known and
putative members of the MPH family (Figure S5).
Discussion
Antibiotic resistance is manifested through a number of different
mechanisms including target alteration, control of drug influx and
efflux, and through highly efficient enzyme-mediated inactivation.
Resistance can emerge relatively quickly in the case of some
mutations in target genes and there is evidence that antibiotics
themselves can promote such mutations [43,44,45,46]; however,
resistance to most antibiotics occurs through the aegis of extremely
efficient enzymes, efflux proteins and other transport systems that
often are highly specialized towards specific antibiotic molecules.
Such elements are the result of evolution through natural selection;
this therefore implies that antibiotic resistance has a long
evolutionary past. A growing body of evidence suggests that
non-pathogenic environmental organisms are a reservoir of
resistance genes that have the potential to be transferred to
pathogens [31,47,48]. The problem of antibiotic resistance in
clinical settings therefore likely has its origins in the environment.
One of the challenges in studying the evolution and prevalence
of resistance is the massive use of antibiotics in the clinic and in
agriculture over the past seven decades that makes identifying
environments that have not been impacted by anthropogenic
antibiotics difficult. Studying resistance in pristine environments
that have not been exposed to human antibiotic use provides a
critical measure of the genetic diversity of resistance that is
essential to our understanding of resistance gene prevalence and
evolution. Lechuguilla Cave provides an outstanding ecosystem
that has been isolated for over 4 million years. The cave’s geologic
features, including the impermeable siltstone caprock which
prevents rapid influx of surface water, great depth, and long
isolation from the surface, rules out the possibility of exposure to
Figure 4. Inactivation of Telithromycin by B. paraconglomeratum strain LC44. After incubation of B. paraconglomeratum in the presence of
20 mg/ml telithromycin, chemical modification was determined by the loss of antimicrobial activity of the clarified culture supernatant associated
with modification of telithromycin as assessed by LC-MS. LC-MS analysis of the resulting inactive extract indicated a shift of retention time and an
increase in m/z by 80 consistent with phosphorylation.
doi:10.1371/journal.pone.0034953.g004
Figure 5. Induction of daptomycin resistance in Paenibacillus lautus LC231. LC231 was cultured in TSB supplemented with 1.25 mM CaCl2
and 4 mg/ml daptomycin added from start (zero time point) (1) or early log phase (2). Growth was compared to growth control with no drug (3).
Arrow represents the time point at which daptomycin was added during early log phase.
doi:10.1371/journal.pone.0034953.g005
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tion through water bodies. As a result Lechuguilla Cave is an ideal
ecosystem for investigating microbes that have not been exposed
to anthropogenic antibiotics.
We surveyed the antibiotic susceptibility of 93 bacterial strains
isolated from Lechuguilla Cave. This was a genetically diverse
collection of oligotrophic organisms (Figure S1), highly adapted to
survive in a nutrient limited environment [22]. Like surface
organisms [11], the majority of these strains were multidrug
resistant indicating that antibiotic resistance is a common and
widespread phenotype in pristine, unimpacted environments;
however, there are differences in the pattern of resistance. For
example, we measured little resistance to the synthetic antibiotics
ciprofloxacin and linezolid, while resistance to natural product
antibiotics was more prevalent. Unlike surface bacteria, we also
detected very little resistance to tetracycline, glycopeptide
(vancomycin), rifamycin (rifampicin) and lipopeptide (daptomycin)
natural product antibiotics. There are several possible reasons for
these differences. First, this survey includes multiple bacterial
genera across five phyla, while our original sampling focused on
Table 2. Summary of Antibiotic Inactivation Studies for Gram-Negative Isolates.
Antibiotic Resistant Strains Number of antibiotic Inactivation Strains Mechanism of Inactivation
Apramycin 10 0 -------
Gentamicin 11 0 -------
Neomycin 24 0 -------
Streptomycin 30 0 -------
Telithromycin 17 0 -------
Clindamycin 39 0 -------
Chloramphenicol 28 2 Acetylation
Trimethoprim 35 0 -------
Cephalexin 36 14 Hydrolysis
Cefotaxime 12 4 Hydrolysis
Ampicillin 30 13 Hydrolysis
Piperacillin 30 16 Hydrolysis
Strains were grown in 50% TSB for 5 days in presence of 20 mg/ml antibiotic. Conditional media was used for setting up disk diffusion assays and LC-MS analyses.
Inactivation was defined as the absence of a zone of clearance around the disk. Hydrolytic mechanism of ß-lactam resistance is inferred.
doi:10.1371/journal.pone.0034953.t002
Figure 6. Genetic context of mph genes in Brachybacterium strains. A genetic map was constructed using available genome sequences of
Brachybacterium strains and shown above is a schematic of translated protein query based on BLAST analysis. The MPH sequence is shown in red and
homologous sequences are marked with identical colors.
doi:10.1371/journal.pone.0034953.g006
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including antibiotics, it is logical that actinomycetes would also be
enriched in resistance elements. Second, the isolate sample size is
smaller in this study in comparison to our previous study and we
have likely not examined the full resistome of both the culturable
and non-culturable microbiome. Further studies of both surface
and cave microbiomes including more extensive cultivation and
metagenomic analysis are therfore necessary to interpret the
results with more confidence.
Aminoglycoside antibiotic resistance was more common in
Lechuguilla Cave isolates as compared to surface actinomycetes.
This may reflect the biosynthetic capacity of antibiotic producing
bacteria in Lechuguilla Cave and the production of these
antibiotics by species within the cave. A survey of the acti-
nomycetes in our collection using oligonucleotide primers designed
to amplify aminoglycoside biosynthetic genes failed to identify
potential aminoglycoside producers; however linking resistance to
antibiotic production will require an extensive and systematic
survey of the cave microbiome and resistome that is beyond the
objectives of this work.
The mechanisms of antibiotic modification and inactivation
are evidence of highly specific evolutionary adaptations to evade
the cytotoxic action of these antibiotics. The high level of ß-
lactam antibiotic resistance by hydrolysis parallels that of surface
bacteria and the result of genetically diverse ß-lactamases that are
widespread in microbial genomes. Similarly, chloramphenicol
acetylation was also detected, an activity that is well established
in surface bacterial isolates [49]. Nonetheless, the hydrolytic
inactivation of daptomycin in isolates of P. lautus was unexpected.
We recently showed that high G+C content actinomycetes use
a hydrolytic ring-opening reaction as a common strategy of
daptomycin inactivation [37], and this work further exposes the
susceptibility of daptomycin’s structure to hydrolytic cleavage.
We also provide the first evidence that daptomycin inactivation
can occur within the low G+C content bacteria Firmicutes, for
which daptomycin’s use is approved; a mechanism that clinical
microbiologists should be on alert for emergence in pathogens.
The inducible activity in P. lautus is very likely catalyzed by an
EDTA-sensitive ring-opening esterase/protease [Figure S3]. Our
efforts to purify the associated protein were unsuccessful due to
instability of the activity (possibly by autocatalytic digestion);
however, a similar inducible activity was recapitulated in a surface
strain of P. lautus. This is intriguing as it suggests either involvement
of a specific receptor for daptomycin or a non-specific response to
the physiological impact of daptomycin bioactivity.
The observation of two distinct macrolide inactivation mech-
anisms in the Lechuguilla bacterial isolates was also intriguing. In
the resistant Streptomyces strains we determined that antibiotic
modification by glycosylation was the primary mechanism of
inactivation, a mechanism that is known in surface actinomycetes
[11]. On the other hand, we established that the mechanism of
macrolide inactivation in B. paraconglomeratum is through phos-
phorylation at position 29 catalyzed by a member of the MPH class
of antibiotic kinases. Previously identified mph genes are encoded
on plasmids found in clinically resistant isolates of the pathogens
Escherichia coli, Staphylococcus aureus, Pasteurella multocida and Pseudo-
monas aeruginosa [36]. This is the first report of mph genes from
environmental bacteria as a potential source of the genes currently
circulating in pathogens. The presence of a transposase-like gene
upstream of mph from a surface strain of B. faecium points to a
potential history of horizontal gene transfer (Figure 6). It is possible
that mph genes have been circulating among bacterial populations
before the cave was sealed off millions of years ago, resulting in an
mph gene that is a shared trait between both terrestrial and cave
bacteria.
There are two likely explanations for retention of the mph genes
with same biochemical properties despite the long isolation of the
Brachybacterium strains: (i) these genes could serve a physiologic or
metabolic function unrelated to antibiotic resistance (although the
genetic context (Figure 6) does not suggest an obvious role); or (ii)
these genes are resistance elements for conferring antibiotic
resistance. We could not detect any macrolide biosynthetic gene
clusters in bacteria collected in the same region as B. paraconglomer-
atum (as evidenced by a absence of the signature macrolide D-
desosamine biosynthesis gene, eryCVI, not shown); however the
actinomycete small sample size does not rule out the possibility of
the presence of hitherto undetected macrolide producers within
the cave.
This work demonstrates that antibiotic resistance is widespread
in the environment even in the absence of anthropogenic
antibiotic use. Lechuguilla Cave represents a remarkable ecosys-
tem that has been isolated for millions of years, well before the
clinical and agricultural use of antibiotics. The presence of
multidrug resistant organisms even in this pristine environment
reinforces the notion that the antibiotic resistome is an ancient and
pervasive component of the microbial pangenome. Given the
nutrient-limited nature of the cave environment, it is likely that
competition for resources plays a dominant role in species
Table 3. Kinetic parameters for MPH (29)-II from B.
paraconglomeratum.
Substrate
Lactone
Ring Km (mM) kcat (s
21)K i (mM)
kcat/Km(s
21
M
21)
Erythromycin
1 14 43.8611.3 0.101 - 2.30610
3
Clarithromycin 14 21.965.45 0.106 - 4.82610
3
Telithromycin 14 12.265 0.04 6006285 3.52610
3
Roxithromycin 14 58.98610.9 0.202 - 3.42610
3
Azithromycin 15 53.9767.59 0.168 - 3.14610
3
Spiramycin 16 45.6614.9 0.173 2926108 3.79610
3
Tylosin 16 222629.2 0.197 66.468.92 8.87610
2
GTP
2 - 10.260.53 0.093 - 9.3610
4
1- GTP held at 200 mM for antibiotic substrates, 2-erythomycin held at 400 mM.
doi:10.1371/journal.pone.0034953.t003
Table 4. Kinetic parameters for MPH (29)-II from B. faecium
DSM 4810.
Substrate
Lactone
Ring Km (mM) kcat (s
21)K i (mM)
kcat/Km(s
21
M
21)
Erythromycin
1 14 38.266.24 0.192 - 5.03610
3
Clarithromycin 14 42.066.26 0.286 - 6.81610
3
Telithromycin 14 23.964.22 0.168 - 7.05610
3
Roxithromycin 14 19.362.60 0.262 - 1.36610
4
Azithromycin 15 60.668.86 0.312 - 5.18610
3
Spiramycin 16 17.363.18 0.157 - 9.10610
3
Tylosin 16 14.564.00 0.088 - 6.07610
2
GTP
2 - 16.061.3 0.203 - 1.27610
4
1- GTP held at 200 mM for antibiotic substrates, 2-erythomycin held at 400 mM.
doi:10.1371/journal.pone.0034953.t004
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adaptations, from changes in cell physiology and growth, to the
production of antimicrobials to outcompete nutritional rivals.
Equally important could be the acquisition and development of
defense mechanisms to enable flexibility and growth in the
presence of noxious bioactive compounds and limit the effective-
ness of such competitors in the ecosystem.
Given the relatively small sample size of this study, the
observation of two previously unidentified mechanisms of
antibiotic resistance (e.g. daptomycin hydrolysis) suggests that
significant genetic diversity may be present in the environment
and capable of being marshaled in the presence of antimicrobial
agents. The available genetic diversity extant in microbial
genomes dwarfs our ability to introduce antibiotics in to clinical
use. Furthermore, the microbial chemical ecology of bioactive
compounds such as antibiotics is not well understood and as such
the resistome includes mechanisms that very likely have not been
evolved simply to evade the effects of molecules that we have
termed antibiotics [50]. This fact further underlines the impor-
tance of the judicious use of antibiotics to avoid selection of
existing resistance elements and their subsequent mobilization
through microbial communities thereby limiting the effectiveness
of these drugs to treat infectious diseases. The remarkable genetic
diversity of the antibiotic resistome, uncovered in this and other
studies has additional practical application as an ‘early warning
system’ for new drugs introduced into the clinic. Resistance
mechanisms in the environmental resistome can emerge in the
clinics and the clinical community should be aware of them; for
example our discovery of hydrolytic mechanisms of daptomycin
resistance. Finally, the diversity in the resistome also suggests that
there are a myriad of bioactive molecules with antibiotic properties
waiting to be discovered. Some of these may have the potential to
be productive leads as antibiotics or as improved scaffolds that can
evade existing clinical resistance.
Materials and Methods
Antibiotic Resistance Screen of Cave Strains
A sample of 93 bacterial strains were isolated from three deep,
remote sample sites in Lechuguilla Cave (Figure 1) under a permit
for sample collection provided by the US National Park Service
(Permit CAVE-2007-SCI-0009 for Study CAVE-00049). These
strains were isolated on a variety of culture media that resembled
the carbon and energy sources thought to be available to
microorganisms within the cave (see Text S1). Following single
colony isolation, these isolates were grown in dilute (50%) Tryptic
Soy Broth (TSB) at 30uC for 3–5 days and frozen stocks were
prepared in 96 well plate format (1:10 dilution of cultures in 80%
glycerol). Master plates containing 150 ml 50% TSB were
inoculated from the frozen stock plates using a replica head
platter and grown at 30uC for 3–5 days. The inoculum plate was
prepared from the master plate as a 1:100 dilution in 50% TSB.
Assay plates containing 50% TSB (140 ml volume) in the presence
and absence of 20 mg/ml antibiotic (named resistance plates and
growth plates respectively) were inoculated with 10 ml/well of the
inoculum plate and incubated at 30uC for 5 days. All studies using
the antibiotic daptomycin were carried out in cultures supple-
mented with 1.25 mM–2.5 mM CaCl2. Screens were performed
in duplicate and data collected as OD600 after 5 days. Resistance
plate data were normalized to the growth control plates and
resistance was defined as more than 50% growth in the presence of
an antibiotic.
Secondary assays of resistance
Strains positive for antibiotic resistance in the primary screen
were confirmed by determination of their MIC and further
analyzed for their ability to inactivate the antibiotic. To determine
MIC, cultures (5 ml) containing 50% TSB were inoculated with a
single isolated colony of each strain of interest and grown shaking
at 250 rpm at 30uC for 5 days. MIC determinations were
conducted in 96 well U- bottom MIC plates (VWR) containing
50% TSB media and supplemented with antibiotic, (ten 2-fold
serial dilution of antibiotic, final concentration ranging from
0.5 mg/ml to 128 mg/ml). Cultures were diluted to OD600 of 0.08–
0.1 in 0.85% NaCl and MIC plates were inoculated with 1:20
dilution of this suspension. Plates were incubated at 30uC for 5
days. Escherichia coli ATCC 29522, Staphylococcus aureus ATCC
29213 and Enterococcus faecalis ATCC 29212 were used as control
strains. MIC testing was performed in duplicate, where MIC was
defined as the drug concentration showing no visible growth.
In order to evaluate resistant strains for antibiotic inactivation,
cultures containing 5 ml of 50% TSB in the presence and absence
of 20 mg/ml of antibiotic were inoculated with 3–5 single isolated
colonies of strain of interest and cultures were grown at 30uC for 5
days. Uninoculated controls were also prepared. After growth at
30uC for 5 days, cultures were centrifuged for 20 minutes at
16,8006g and conditioned media was collected. One of the
following susceptible organisms/test organisms was used for
antimicrobial susceptibility testing (antimicrobial disk diffusion
assay): Bacillus subtilis, Micrococcus luteus and Staphylococcus saprophy-
ticus ATCC 15305. Inocula of test organisms were prepared to the
0.5 McFarland standard using the direct colony suspension
method according to the Clinical and Laboratory Standard
Institute guidelines [51]. Susceptible organisms were plated on
LB Agar and conditioned media (20–30 ml) was spotted on sterile
paper disks prior to incubation at 37uC overnight. Inactivation was
defined as complete absence of a zone of inhibition.
B. paraconglomeratum LC44 Genome Sequencing and
Assembly
B. paraconglomeratum LC44 was grown in 5 ml 50% TSB at 30uC
for 5 days. Genomic DNA was isolated using QIAGEN DNeasy
Blood and Tissue Kit 250 (Qiagen, Germany) with one
modification of the manufacturer’s protocol for cell lysis: 4 mlo f
RNase (100 mg/ml in Buffer TE) was added to the reaction
mixture and incubated at room temperature for 2 minutes before
washing the spin column. Genomic DNA was submitted for
shotgun sequencing to Roche 454 Life Sciences Genome
Sequencer at Farncombe Metagenomics Facility, McMaster
University. Approximately one quarter of a 454 PTP was used
for Titanium pyrosequencing on a 454 GS FLX. Additionally,
8059104 Illumina GAIIx 71 bp paired end reads were sequenced
by Ambry Genetics (Aliso Viejo, California). After aggressive
quality trimming and filtering, the approximately 5.5 million
remaining Illumina reads (about 706coverage) and 262995 454
reads (about 236coverage) were assembled using MIRA version
3.4 with the ‘-job=denovo,genome,454,accurate,solexa’ switches
[52]. The resulting contig sequences of the assembly were
deposited in Genbank as a WGS project under accession
AGSO00000000. The protein sequence of E. coli MPH (29)-Ia
(accession BAA03776) was used to query the assembled sequences
using translated blast in order to find a gene responsible for the
observed macrolide phosphotransferase activity. A good candidate
was found on contig AGSO00000004 beginning at bp 76533 and
a blastx search was performed against the NCBI non-redundant
protein database where the top hits corresponded to sequences
annotated as putative APH and MPH proteins.
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Phosphotransferases
The candidate macrolide phosphotransferase from B. paracon-
glomeratum (mphE) was synthesized by GenScript (USA) with codon
optimization for E. coli expression and cloned into pET28b with
Nde I and Hind III restriction sites. The plasmid containing MPH
was transformed into E. coli BL21 (DE3) and the resulting colonies
were grown overnight at 37uC in LB media supplemented with
50 mg/ml kanamycin. For overexpression, 1 L LB cultures
supplemented with 50 mg/ml kanamycin were subcultured from
the overnight culture at 1% (v/v) and grown at 37uCt oa nO D 600
of 0.5–0.7. The cells were chilled on ice for 15 minutes. Protein
expression was induced with 1 mM isopropyl-b-D-thiogalactopyr-
anoside at 16uC for 16 hours. The cells were harvested and stored
at 220uC until further use. For protein purification, the cells were
resuspended in lysis buffer (50 mM HEPES, 300 mM NaCl,
10 mM Imidazole, pH 7.5), 1 mM phenylmethanesulfonylfluoride
and 1 mg/ml pancreatic-bovine DNase and cells were lysed using
T-S series cell disrupter. Protein was purified by standard
immobilized metal affinity chromatography followed by gel
filtration and stored in 10% glycerol at 220uC.
Steady State Kinetic Analysis of MPH(29)
Kinetic parameters of MPHs were determined in triplicate
using Pyruvate Kinase/Lactate Dehydrogenase coupled assay [53].
Phosphorylation of macrolides by MPHs was monitored by
absorbance of NADH (340 nm) in 96 well format using a
SpectraMax reader. The reaction was initiated with macrolide or
nucleotide (GTP). When monitoring macrolide dependence,
200 mM GTP was used and the macrolide concentration ranged
from 3.2 mM and 400 mM. For nucleotide dependence, 200 mM
macrolidewasusedandthefinalconcentrationsofGTPrangedfrom
7.82 mM to 2000 mM. All reactions were performed in triplicate.
The initial rates were fit to equation 1 or 2 (substrate inhibition)
using Grafit 4.0 software (Erithacus Software, Staines, UK):
v~Vmax:½S =Kmz½S ð 1Þ
v~Vmax   S=(KmzS   (1zS=Ki)) ð2Þ
Growth Analysis of Paenibacillus lautus LC231 with
Daptomycin
Analyses were performed in 96-well flat bottom plates (200 ml
volume total) using 50% TSB supplemented with 1.25 mM CaCl2
as a growth medium. Inocula represented 1:200 dilutions of an
overnight culture, standardized to an OD600 of 0.1. The following
conditions were tested in duplicate: (1) no daptomycin, (2)4mg/ml
daptomycin and (3)4mg/ml daptomycin added after 10.5 hours
(early log phase). Plates were incubated while shaking at 30uC and
the data was collected as an OD600 every 30 minutes using a
Tecan Sunrise plate reader. Similar studies were conducted with a
surface strain of P. lautus (ATCC 43898) except that the organism
was grown in full strength TSB.
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Text S1 Supporting materials and methods.
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Figure S1 Lechuguilla cave microbiome. A) Chart of the
distribution of bacterial isolates sampled in this work. B)
Consensus phylogram of bacterial strains used in this study. The
tree was created using 16 S rRNA gene sequences. Node values
represent the likelihood of the represented partition at each branch
(based on 1000 maximum likelihood bootstrap analyses).
(TIF)
Figure S2 Inhibition of daptomycin inactivation by a
series of common protease and esterase inhibitors.
Inhibition studies were performed with crude culture supernatant
in triplicate at 200 mg/ml of daptomycin with all traces of calcium
previously removed. Error bars are 1 S.D..
(TIF)
Figure S3 Structure of telithromycin and telithromycin
phosphate.
(TIF)
FigureS4
31P– NMRspectraoftelithromycinphosphate.
(TIF)
Figure S5 Phylogenetic Analysis of MPH/MPH-like
proteins. Aminoglycoside Phosphotransferases (APHs) were
collapsed into a single branch (APH sequences) which was used
as an outgroup in this analysis of amino acid sequence. Note that
the scale bar represents 0.1 mutations/site.
(TIF)
Table S1 Media Used for Initial Bacterial Cultivation.
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Table S2 List of strains used in this study.
(DOCX)
Table S3 Telithromycin Inactivation in Cave Isolates.
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Table S4 Tandem mass spectrometry analysis of ring-
opened daptomycin by Paenibacillus lautus LC231.
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Table S5 Chloramphenicol Inactivation in Cave Strains.
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Table S6
1H Chemical Shifts of Telithromycin and
Inactivated Product of B. paraconglomeratum LC44 in
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13C Chemical Shifts of Telithromycin and
Inactivated Product of B. paraconglomeratum LC44 in
DMSO-d6 (ppm).
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